Advertisement
Screener

ALPHATEC HOLDINGS, INC. (ATEC) Research and Development Asset Acquired Other than Through Business Combination, Written-off

3.3 / 5 stars · 52/80 Roast Me

ALPHATEC HOLDINGS, INC. Research and Development Asset Acquired Other than Through Business Combination, Written-off

ALPHATEC HOLDINGS, INC. (ATEC) reported Research and Development Asset Acquired Other than Through Business Combination, Written-off of $274.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-31.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff · last filed 2017-03-31

  • ALPHATEC HOLDINGS, INC. research and development asset acquired other than through business combination, written-off for the quarter ending 2010-12-31 was $0.00.
  • ALPHATEC HOLDINGS, INC. research and development asset acquired other than through business combination, written-off for the quarter ending 2010-09-30 was $2.42M.
  • ALPHATEC HOLDINGS, INC. research and development asset acquired other than through business combination, written-off for the quarter ending 2010-06-30 was $92.00K.
  • ALPHATEC HOLDINGS, INC. research and development asset acquired other than through business combination, written-off for fiscal 2015 was $274.00K, a 48.01% decline from fiscal 2014.
  • ALPHATEC HOLDINGS, INC. research and development asset acquired other than through business combination, written-off for fiscal 2014 was $527.00K.
  • ALPHATEC HOLDINGS, INC. research and development asset acquired other than through business combination, written-off for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
  • ALPHATEC HOLDINGS, INC. research and development asset acquired other than through business combination, written-off for fiscal 2012 was $341.00K.
Period endResearch and Development Asset Acquired Other than Through Business Combination, Written-off 3 monthResearch and Development Asset Acquired Other than Through Business Combination, Written-off 6 monthResearch and Development Asset Acquired Other than Through Business Combination, Written-off 9 monthResearch and Development Asset Acquired Other than Through Business Combination, Written-off 12 month
2015-12-31$274.00K
10-K · filed 2017-03-31
2014-12-31$527.00K
10-K · filed 2017-03-31
2013-12-31$0.00
10-K · filed 2016-03-15
2012-12-31$341.00K
10-K · filed 2015-02-27
2011-12-31$0.00
10-K · filed 2014-03-20
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-05
$2.42M
derived: sum of 2 quarters · filed 2013-03-05
$2.52M
derived: sum of 3 quarters · filed 2013-03-05
$2.97M
10-K · filed 2013-03-05
2010-09-30$2.42M
10-Q · filed 2011-11-04
$2.52M
derived: sum of 2 quarters · filed 2011-11-04
$2.97M
10-Q · filed 2011-11-04
2010-06-30$92.00K
10-Q · filed 2011-08-08
$542.00K
10-Q · filed 2011-08-08
2009-12-31$6.38M
10-K · filed 2012-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
NovoCure Ltd (NVCR)$1.886B-11.87
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66